Propensity Score Analysis of the Role of Initial Antifungal Therapy in the Outcome of Candida glabrata Bloodstream Infections

Candida glabrata isolates have reduced in vitro susceptibility to azoles, which raises concerns about the clinical effectiveness of fluconazole for treating bloodstream infection (BSI) by this Candida species. We aimed to evaluate whether the choice of initial antifungal treatment (fluconazole versu...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Antimicrob Agents Chemother
Main Authors: Puig-Asensio, M., Fernández-Ruiz, M., Aguado, J. M., Merino, P., Lora-Pablos, D., Guinea, J., Martín-Dávila, P., Cuenca-Estrella, M., Almirante, B.
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2016
Assuntos:
Clinical Therapeutics
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4879398/
https://ncbi.nlm.nih.gov/pubmed/26976872
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00195-16
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares